These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 19356482)

  • 1. Is the magnet a better crystal ball for predicting response to cardiac resynchronization therapy?
    Gorcsan J
    JACC Cardiovasc Imaging; 2008 Sep; 1(5):569-71. PubMed ID: 19356482
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiac magnetic resonance assessment of dyssynchrony and myocardial scar predicts function class improvement following cardiac resynchronization therapy.
    Bilchick KC; Dimaano V; Wu KC; Helm RH; Weiss RG; Lima JA; Berger RD; Tomaselli GF; Bluemke DA; Halperin HR; Abraham T; Kass DA; Lardo AC
    JACC Cardiovasc Imaging; 2008 Sep; 1(5):561-8. PubMed ID: 19356481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of speckle-strain in a multiparametric approach to dyssynchrony imaging.
    Marwick TH
    JACC Cardiovasc Imaging; 2011 Apr; 4(4):375-7. PubMed ID: 21492812
    [No Abstract]   [Full Text] [Related]  

  • 4. Model-based navigation of left and right ventricular leads to optimal targets for cardiac resynchronization therapy: a single-center feasibility study.
    Laksman Z; Yee R; Stirrat J; Gula LJ; Skanes AC; Leong-Sit P; Manlucu J; McCarty D; Turkistani Y; Scholl D; Rajchl M; Goela A; Islam A; Thompson RT; Drangova M; White JA
    Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1040-7. PubMed ID: 25221334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined dyssynchrony and scar imaging with cardiac magnetic resonance imaging predicts clinical response and long-term prognosis following cardiac resynchronization therapy.
    Taylor AJ; Elsik M; Broughton A; Cherayath J; Leet A; Wong C; Iles L; Butler M; Pfluger H
    Europace; 2010 May; 12(5):708-13. PubMed ID: 20190262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical benefit of cardiac resynchronization therapy with a defibrillator in patients with an ejection fraction > 35% estimated by cardiac magnetic resonance.
    Fabregat-Andrés O; García-González P; Valle-Muñoz A; Estornell-Erill J; Pérez-Boscá L; Palanca-Gil V; Payá-Serrano R; Quesada-Dorador A; Morell S; Ridocci-Soriano F
    Rev Esp Cardiol (Engl Ed); 2014 Feb; 67(2):107-13. PubMed ID: 24795117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of LV lead position in cardiac resynchronization therapy using different imaging modalities.
    Becker M; Altiok E; Ocklenburg C; Krings R; Adams D; Lysansky M; Vogel B; Schauerte P; Knackstedt C; Hoffmann R
    JACC Cardiovasc Imaging; 2010 May; 3(5):472-81. PubMed ID: 20466342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of the longest intrapatient left ventricular electrical delay may predict acute hemodynamic improvement in patients after cardiac resynchronization therapy.
    Zanon F; Baracca E; Pastore G; Fraccaro C; Roncon L; Aggio S; Noventa F; Mazza A; Prinzen F
    Circ Arrhythm Electrophysiol; 2014 Jun; 7(3):377-83. PubMed ID: 24668162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of dysfunctional remote myocardium in left ventricular anterior aneurysms and improvements following surgical ventricular restoration using cardiac magnetic resonance imaging: preliminary results.
    Adhyapak SM; Menon PG; Parachuri VR; Shetty DP; Fantini F
    Interact Cardiovasc Thorac Surg; 2014 Sep; 19(3):368-74. PubMed ID: 24907238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of left ventricular lead position relative to scar location on response to cardiac resynchronization therapy: a model study.
    Huntjens PR; Walmsley J; Ploux S; Bordachar P; Prinzen FW; Delhaas T; Lumens J
    Europace; 2014 Nov; 16 Suppl 4():iv62-iv68. PubMed ID: 25362172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study.
    Hsu JC; Solomon SD; Bourgoun M; McNitt S; Goldenberg I; Klein H; Moss AJ; Foster E;
    J Am Coll Cardiol; 2012 Jun; 59(25):2366-73. PubMed ID: 22698490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac magnetic resonance imaging to assess and predict improvement of myocardial function after percutaneous coronary intervention: a new standard?
    Kutcher MA
    JACC Cardiovasc Interv; 2010 Apr; 3(4):401-2. PubMed ID: 20398867
    [No Abstract]   [Full Text] [Related]  

  • 13. A novel tool to assess systolic asynchrony and identify responders of cardiac resynchronization therapy by tissue synchronization imaging.
    Yu CM; Zhang Q; Fung JW; Chan HC; Chan YS; Yip GW; Kong SL; Lin H; Zhang Y; Sanderson JE
    J Am Coll Cardiol; 2005 Mar; 45(5):677-84. PubMed ID: 15734610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac imaging and cardiac resynchronization therapy: time to get in phase.
    Zaret BL
    JACC Cardiovasc Imaging; 2008 Sep; 1(5):614-6. PubMed ID: 19356490
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiac magnetic resonance imaging for the assessment of ventricular function, geometry, and viability before and after surgical ventricular reconstruction.
    Hüther J; Doenst T; Nitzsche S; Thiele H; Mohr FW; Gutberlet M
    J Thorac Cardiovasc Surg; 2011 Dec; 142(6):1515-22.e1. PubMed ID: 21907357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial.
    Ruwald MH; Solomon SD; Foster E; Kutyifa V; Ruwald AC; Sherazi S; McNitt S; Jons C; Moss AJ; Zareba W
    Circulation; 2014 Dec; 130(25):2278-86. PubMed ID: 25301831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of myocardial scar characterization to predict ventricular arrhythmia in cardiac resynchronization therapy.
    Fernández-Armenta J; Berruezo A; Mont L; Sitges M; Andreu D; Silva E; Ortiz-Pérez JT; Tolosana JM; de Caralt TM; Perea RJ; Calvo N; Trucco E; Borràs R; Matas M; Brugada J
    Europace; 2012 Nov; 14(11):1578-86. PubMed ID: 22562658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Targeting the Heart" in Heart Failure: Myocardial Recovery in Heart Failure With Reduced Ejection Fraction.
    Wilcox JE; Fonarow GC; Ardehali H; Bonow RO; Butler J; Sauer AJ; Epstein SE; Khan SS; Kim RJ; Sabbah HN; Díez J; Gheorghiade M
    JACC Heart Fail; 2015 Sep; 3(9):661-9. PubMed ID: 26362444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left Ventricular Reverse Remodeling With Biventricular Versus Right Ventricular Pacing in Patients With Atrioventricular Block and Heart Failure in the BLOCK HF Trial.
    St John Sutton M; Plappert T; Adamson PB; Li P; Christman SA; Chung ES; Curtis AB
    Circ Heart Fail; 2015 May; 8(3):510-8. PubMed ID: 25697851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy.
    Bello D; Shah DJ; Farah GM; Di Luzio S; Parker M; Johnson MR; Cotts WG; Klocke FJ; Bonow RO; Judd RM; Gheorghiade M; Kim RJ
    Circulation; 2003 Oct; 108(16):1945-53. PubMed ID: 14557364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.